These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7295437)

  • 21. Effects of valsartan and indapamide on plasma cytokines in essential hypertension.
    Xie QY; Wang YJ; Sun ZL; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):629-34. PubMed ID: 17062919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium and large arteries in hypertension. Effects of indapamide.
    Safar M; Laurent S; Safavian A; Pannier B; Asmar R
    Am J Med; 1988 Jan; 84(1B):15-9. PubMed ID: 3277415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular and metabolic profile during intervention with urapidil in humans.
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of verapamil in essential hypertension.
    Städler P; Leonardi L; Riesen W; Ziegler W; Marone C; Beretta-Piccoli C
    Clin Pharmacol Ther; 1987 Nov; 42(5):485-92. PubMed ID: 3315389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
    Plante GE; Dessurault DL
    Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indapamide improves flow-induced dilation in hypertensive rats with a high salt intake.
    Matrougui K; Lévy BI; Schiavi P; Guez D; Henrion D
    J Hypertens; 1998 Oct; 16(10):1485-90. PubMed ID: 9814620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma noradrenaline and the pressor action of exogenous noradrenaline in normotensive subjects and patients with essential hypertension.
    Philipp T; Distler A; Cordes U; Wolff HP
    Clin Sci Mol Med Suppl; 1978 Dec; 4():61s-63s. PubMed ID: 282099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antihypertensive effect of indapamide.
    Reyes AJ; Acosta-Barrios T; Leary WP; Van der Byl K
    S Afr Med J; 1983 May; 63(21):804-6. PubMed ID: 6845104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term treatment of essential arterial hypertension with indapamide].
    Fanini A; Vignola D; Poppi A
    Minerva Cardioangiol; 1982 Dec; 30(12):715-9. PubMed ID: 7167233
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of indapamide on phosphate metabolism and vascular reactivity.
    Plante GE; Lafreniere MC; Tam PT; Sirois P
    Am J Med; 1988 Jan; 84(1B):26-30. PubMed ID: 3277416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and tolerance of indapamide in essential hypertension: a multi-centre study in 981 patients.
    Abbou CB
    Curr Med Res Opin; 1985; 9(7):494-9. PubMed ID: 3896658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet alpha 2-adrenoceptor modifications induced by long-term treatment with indapamide in essential hypertension.
    Carretta R; Fabris B; Fischetti F; Muiesan S; Bardelli M; Melchior C; Cesanelli R; Pizzolitto A; Giraldi T; Greco PL
    Am J Med; 1988 Jan; 84(1B):31-5. PubMed ID: 2829625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Once daily indapamide in the treatment of the elderly and young hypertensive.
    Rowlands DB; Glover DR; Young MA; Stallard TJ; Littler WA
    Eur J Clin Pharmacol; 1984; 27(4):397-405. PubMed ID: 6394348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different blood pressure responses to diuretic treatment in normotensive subjects with and without a family history of hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Bianchetti MG
    J Hypertens Suppl; 1983 Dec; 1(2):31-4. PubMed ID: 6599492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.